Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells.
about
The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-β- catenin signaling axis.PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell linesAcetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.AP1G1 is involved in cetuximab-mediated downregulation of ASCT2-EGFR complex and sensitization of human head and neck squamous cell carcinoma cells to ROS-induced apoptosis.Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer
P2860
Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification and validation ...... ce in colorectal cancer cells.
@en
Identification and validation ...... ce in colorectal cancer cells.
@nl
type
label
Identification and validation ...... ce in colorectal cancer cells.
@en
Identification and validation ...... ce in colorectal cancer cells.
@nl
prefLabel
Identification and validation ...... ce in colorectal cancer cells.
@en
Identification and validation ...... ce in colorectal cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Identification and validation ...... ce in colorectal cancer cells.
@en
P2093
P2860
P304
64766-64777
P356
10.18632/ONCOTARGET.8649
P407
P577
2016-04-08T00:00:00Z